Načítá se...
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
α-Glucosidase inhibitors (AGIs) are a class of oral glucose-lowering drugs used exclusively for treatment or prevention of type 2 diabetes mellitus. AGIs act by altering the intestinal absorption of carbohydrates through inhibition of their conversion into simple sugars (monosaccharides) and thus de...
Uloženo v:
| Vydáno v: | Open Heart |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620230/ https://ncbi.nlm.nih.gov/pubmed/26512331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2015-000327 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|